Fletcher Spaght Ventures

FSV Overview

Investment Strategy

Our Team

Advisory Board

Industry Experience

Portfolio Companies


Portfolio Companies

Ikano Therapeutics, Inc.

Ikano Therapeutics, Inc.

Ikano Therapeutics, Inc. (ITI) is a specialty pharmaceutical company focused on developing innovative nasally delivered pharmaceutical products, with a particular focus on drugs treating pain and disorders related to the central nervous system for which there is proven, unsatisfied market need.

ITI-111, Ikano Therapeutic's midazolam nasal spray acquired by Upsher-Smith Laboratories, Inc.

Copyright © 2015 Fletcher Spaght Ventures, LP
All Rights Reserved.
222 Berkeley Street • 20th Floor • Boston, MA 02116
617-247-6700 Telephone • 617-247-7757 Facsimile